HomeKPTI • NASDAQ
add
Karyopharm Therapeutics Inc
Previous close
$4.29
Day range
$4.03 - $4.35
Year range
$3.51 - $21.30
Market cap
35.43M USD
Avg Volume
159.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 30.54M | -9.50% |
Operating expense | 170.42M | 0.58% |
Net income | -30.78M | 26.43% |
Net profit margin | -100.78 | 18.71% |
Earnings per share | -3.60 | 33.33% |
EBITDA | -31.20M | 17.31% |
Effective tax rate | 0.35% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 108.71M | -43.21% |
Total assets | 164.42M | -31.62% |
Total liabilities | 350.44M | -6.96% |
Total equity | -186.02M | — |
Shares outstanding | 8.42M | — |
Price to book | -0.19 | — |
Return on assets | -44.20% | — |
Return on capital | -82.27% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -30.78M | 26.43% |
Cash from operations | -25.81M | -38.88% |
Cash from investing | 14.80M | -44.88% |
Cash from financing | 680.00K | 157.58% |
Net change in cash | -10.35M | -220.23% |
Free cash flow | -7.17M | -209.50% |
About
Founded
2008
Headquarters
Website
Employees
279
